SPINEMarketGroup

Spine Industry News

CASCADIA TL Interbody System

By

The CASCADIA  TL Interbody System includes a full range of implant sizes carefully designed to accommodate the vertebral anatomy. The streamlined instrumentation is designed to aid in consistent and accurate implant placement. K2M’s Lamellar 3D Titanium Technology™ incorporates a porous structure in conjunction with rough surfaces to allow the potential for bony integration throughout the implant.K2M’s Lamellar 3D Titanium Technology™ uses an advanced 3D printing method to create structures that were once considered impractical with traditional manufacturing techniques. Starting with a titanium powder, the implants are grown through the selective application of a high-energy laser beam, allowing for the incorporation of both a porosity and surface roughness that pre-clinical data have associated with bone growth activity.*

FeaturesCASCADIA-TL

  • Titanium Interbody With Approximately 70% Porosity
  • Rough Surfaces Throughout May Allow for Enhanced Cellular Activity
  • Increased Bone Graft Volume Compared to Equivalent K2M PEEK Design
  • Bulleted Nose to Ease Insertion Into Collapsed Disc Spaces

*Pre-clinical data may not represent clinical results.

About TLIF

A transforaminal lumbar interbody fusion (TLIF) is performed to remove a portion of a disc that is the source of back or leg pain. Bone graft is used to fuse the spinal vertebrae after the disc is removed. TLIF provides fusion of the front and back of the lumbar spine. The front portion of the spine, called the anterior column, is stabilized by the interbody spacer and bone graft. The back portion, or posterior column, is locked in place with pedicle screws, rods and additional bone graft, alongside the backs of the vertebra.

About K2M

K2M

K2M, Inc. is a Public Company (NASDAQ-KTWO) focused on the research, development, and commercialization of innovative solutions for thetreatment of complex spinal pathologies and minimally invasive procedures. The company is recognized as a global leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s product development pipeline includes: spinal stabilization systems, minimally invasive systems, biologics, and other advancing technologies, such as motion preservation, annular repair, and nucleus replacement. http://www.k2m.com